GALDERMA GROUP N (GALD.SW) has a MoatMap StockRank of 50/100 based on Quality (58/100), Value (17/100), and Momentum (62/100) factor scores. The current signal is HOLD. Galderma Group, a dermatology company (Q: 46), possesses an average quality score that falls short of the stringent 'quality compounder' criteria (high ROIC, un-copyable moat) of the Terry Smith lens. Without a clear and powerful asymmetric macro tailwind that is not fully priced, this company does not meet the high-conviction standards of the fund.